Arzneimittel mit bevacizumab · EU

• Abevmy
  bevacizumab
  EMEA/H/C/005327
  Biosimilar Collaborations Ireland Limited
• Alymsys
  bevacizumab
  EMEA/H/C/005286
  Mabxience Research SL
• Avastin
  bevacizumab
  EMEA/H/C/000582
  Roche Registration GmbH
• Avzivi
  bevacizumab
  EMEA/H/C/005574
  FGK Representative Service GmbH
• Aybintio
  bevacizumab
  EMEA/H/C/005106
  Samsung Bioepis NL B.V.
• Ipique
  bevacizumab
  EMEA/H/C/005433
  Rotterdam Biologics B.V.
• Kyomarc
  bevacizumab
  EMEA/H/C/004360
  Amgen Europe B.V.
• Lytenava
  bevacizumab
  EMEA/H/C/005723
  Outlook Therapeutics NL B. V.
• Mvasi
  bevacizumab
  EMEA/H/C/004728
  Amgen Europe B.V.
• Orblid
  bevacizumab
  EMEA/H/C/006392
  Laboratoires Delbert
• Oyavas
  bevacizumab
  EMEA/H/C/005556
  STADA Arzneimittel AG
• Vegzelma
  bevacizumab
  EMEA/H/C/005534
  Celltrion Healthcare Hungary Kft.
• Zirabev
  bevacizumab
  EMEA/H/C/004697
  Pfizer Europe MA EEIG
• Equidacent
  bevacizumab
  EMEA/H/C/005181
  Centus Biotherapeutics Europe Limited
• Lextemy
  bevacizumab
  EMEA/H/C/005611
  Mylan IRE Healthcare Limited
• Onbevzi
  bevacizumab
  EMEA/H/C/005640
  Samsung Bioepis NL B.V.